Typical filing
Little or no relationship
Filing-weighted · strength 0.18 · 794 quarterly observations
59 companies · 1,161 scored filings
Filing-weighted · strength 0.18 · 794 quarterly observations
Company-balanced · straight-line 0.16 · 54 companies
The filing-weighted result gives more influence to companies with more filings. The company-balanced result gives each company equal weight. Why are these different?
| Filing-weighted Spearman | 0.18 |
|---|---|
| Filing-weighted Pearson | 0.03 |
| Winsorized Pearson (when n≥20) | 0.05 |
| Company-balanced Pearson | 0.16 |
Each dot represents one 10-Q filing. Extreme percent changes are capped so one point does not flatten the rest. How to read this chart
| Company | Relationship | Sample |
|---|---|---|
| MTD Mettler Toledo When hundreds of companies are tested, some can appear statistically notable by chance. This badge means the relationship still stood out after that adjustment. Read about FDR | Strong positive Strength 0.88 | 15 quarterly observations |
| IQV IQVIA | Strong positive Strength 0.82 | 14 quarterly observations |
| HCA HCA Healthcare | Strong positive Strength 0.75 | 14 quarterly observations |
| WST West Pharmaceutical Services When hundreds of companies are tested, some can appear statistically notable by chance. This badge means the relationship still stood out after that adjustment. Read about FDR | Strong positive Strength 0.75 | 15 quarterly observations |
| DHR Danaher Corporation When hundreds of companies are tested, some can appear statistically notable by chance. This badge means the relationship still stood out after that adjustment. Read about FDR | Strong positive Strength 0.72 | 15 quarterly observations |
| SOLV Solventum | Moderate positive Strength 0.64 | 8 quarterly observations |
| ELV Elevance Health | Moderate positive Strength 0.58 | 15 quarterly observations |
| ABT Abbott Laboratories | Moderate positive Strength 0.51 | 14 quarterly observations |
| UNH UnitedHealth Group | Moderate positive Strength 0.51 | 15 quarterly observations |
| ZTS Zoetis | Moderate positive Strength 0.50 | 15 quarterly observations |
| LLY Lilly (Eli) | Moderate positive Strength 0.46 | 15 quarterly observations |
| CNC Centene Corporation | Moderate positive Strength 0.46 | 15 quarterly observations |
| ALGN Align Technology | Moderate positive Strength 0.45 | 15 quarterly observations |
| CRL Charles River Laboratories | Moderate positive Strength 0.44 | 15 quarterly observations |
| DGX Quest Diagnostics | Moderate positive Strength 0.43 | 15 quarterly observations |
| PODD Insulet Corporation | Moderate positive Strength 0.42 | 14 quarterly observations |
| CVS CVS Health | Moderate positive Strength 0.42 | 15 quarterly observations |
| MDT Medtronic | Weak positive Strength 0.36 | 15 quarterly observations |
| CAH Cardinal Health | Weak positive Strength 0.35 | 14 quarterly observations |
| UHS Universal Health Services | Weak positive Strength 0.34 | 15 quarterly observations |
| COR Cencora | Weak positive Strength 0.33 | 15 quarterly observations |
| LH Labcorp | Weak positive Strength 0.31 | 15 quarterly observations |
| BDX Becton Dickinson | Weak positive Strength 0.28 | 15 quarterly observations |
| MRK Merck & Co. | Weak positive Strength 0.28 | 15 quarterly observations |
| DXCM Dexcom | Weak positive Strength 0.27 | 15 quarterly observations |
| BAX Baxter International | Weak positive Strength 0.26 | 15 quarterly observations |
| A Agilent Technologies | Weak positive Strength 0.26 | 15 quarterly observations |
| COO Cooper Companies (The) | Weak positive Strength 0.21 | 15 quarterly observations |
| TECH Bio-Techne | Weak positive Strength 0.21 | 15 quarterly observations |
| HSIC Henry Schein | Little or no relationship Strength 0.18 | 15 quarterly observations |
| INCY Incyte | Little or no relationship Strength 0.16 | 14 quarterly observations |
| ISRG Intuitive Surgical | Little or no relationship Strength 0.15 | 15 quarterly observations |
| STE Steris | Little or no relationship Strength 0.15 | 15 quarterly observations |
| VRTX Vertex Pharmaceuticals | Little or no relationship Strength 0.05 | 15 quarterly observations |
| RMD ResMed| | Little or no relationship Strength 0.04 | 15 quarterly observations |
| ABBV AbbVie | Little or no relationship Strength 0.01 | 15 quarterly observations |
| EW Edwards Lifesciences | Little or no relationship Strength 0.01 | 10 quarterly observations |
| MRNA Moderna | Little or no relationship Strength -0.02 | 15 quarterly observations |
| SYK Stryker Corporation | Little or no relationship Strength -0.06 | 15 quarterly observations |
| MCK McKesson Corporation | Little or no relationship Strength -0.06 | 15 quarterly observations |
| PFE Pfizer | Little or no relationship Strength -0.13 | 15 quarterly observations |
| GEHC GE HealthCare | Little or no relationship Strength -0.15 | 10 quarterly observations |
| GILD Gilead Sciences | Little or no relationship Strength -0.15 | 15 quarterly observations |
| AMGN Amgen | Little or no relationship Strength -0.18 | 15 quarterly observations |
| RVTY Revvity | Little or no relationship Strength -0.19 | 15 quarterly observations |
| BMY Bristol Myers Squibb | Weak negative Strength -0.20 | 15 quarterly observations |
| IDXX Idexx Laboratories | Weak negative Strength -0.24 | 15 quarterly observations |
| JNJ Johnson & Johnson | Weak negative Strength -0.24 | 15 quarterly observations |
| ZBH Zimmer Biomet | Weak negative Strength -0.25 | 13 quarterly observations |
| DVA DaVita | Weak negative Strength -0.25 | 15 quarterly observations |
| REGN Regeneron Pharmaceuticals | Weak negative Strength -0.27 | 15 quarterly observations |
| HUM Humana | Weak negative Strength -0.39 | 14 quarterly observations |
| VEEV Veeva Systems | Moderate negative Strength -0.47 | 15 quarterly observations |
| BIIB Biogen | Moderate negative Strength -0.56 | 14 quarterly observations |
Other industries: Communication Services · Consumer Discretionary · Consumer Staples · Energy · Financials · Industrials · Information Technology · Materials